Zinzino AB Reports Impressive 32% Increase in February Revenue Growth

Zinzino AB, a prominent player in the health and wellness sector, shared its preliminary sales report for February 2026, revealing an impressive 32% increase in revenue compared to the same period last year. The total revenue for February amounted to SEK 281.1 million, up from SEK 212.7 million in February 2025. This surge in revenue reflects the company's successful strategies and growing market presence across its sales regions.

One of the remarkable highlights of this report is the performance of Faun Pharma, a subsidiary of Zinzino, which saw its external sales climb to SEK 5.2 million, up from SEK 4.2 million in the previous year. The overall group revenue for Zinzino reached SEK 286.3 million, which is also a significant increase from SEK 216.9 million in the same month last year.

Looking at the accumulated revenue for January and February 2026, the numbers indicate a steady upward trend, showing a 26% increase to SEK 568.6 million compared to SEK 450.8 million during the same period in 2025. These results emphasize Zinzino's resilience and adaptability in a competitive marketplace.

Regional Insights



In the breakdown of revenue across different regions, the data offers insightful observations.

  • - Nordics: Revenue slightly dipped by 9% from SEK 24.8 million to SEK 22.5 million in February, showing a marginal year-to-date decrease of 1%.
  • - Central Europe: This region experienced notable growth with a 43% increase from SEK 57.4 million to SEK 81.8 million, and a substantial year-to-date growth of 35%.
  • - East Europe: Here, revenue saw a decline of 10%, settling at SEK 26.2 million, with a year-to-date decrease of 12% as well.
  • - Southwest Europe: The region reported a 33% increase, with revenues growing from SEK 37.8 million to SEK 50.2 million and a yearly increase of 19%.
  • - The Baltics: This region experienced a minor decline of 3%, reporting SEK 8.5 million, with a year-to-date decrease of 2%.
  • - North America: Perhaps the most impressive performance came from North America, which saw a staggering 108% growth, climbing from SEK 32.5 million to SEK 67.5 million, with year-to-date growth at 104%.
  • - South America: This region exhibited extraordinary growth of 200%, with revenues increasing from SEK 1.2 million to SEK 3.6 million, and a remarkable year-to-date increase of 257%.
  • - Asia-Pacific: Revenues dipped by 6%, ending up at SEK 18.6 million, but showed a slight year-to-date growth of 1%.
  • - Africa: This region showed a good increase of 47% with revenue climbing to SEK 2.2 million and a year-to-date growth of 37%.

Conclusion



Zinzino AB's preliminary sales report for February 2026 illustrates a strong financial performance, signaling robust growth in various regions, particularly North America and South America, where strategies appear to be yielding significant results. The company’s focus on wellness and health products seems to resonate well with consumers, allowing it to navigate the challenges of an ever-evolving marketplace effectively. Zinzino’s management continues to innovate and adapt, positioning itself favorably for sustained growth in the future.

Topics Business Technology)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.